43739 Safety and Tolerability of Tirbanibulin Ointment 1% over a Large Field (up to 100 cm2) in Actinic Keratosis: A Phase 3 Study

Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2023
This article has no abstract
Epistemonikos ID: 2beeb7c792ca3079e602fc82ec4e1fbd4b3a20c0
First added on: Feb 16, 2025